Earlier detection of pulmonary hypertension in the community and expedited referral of high-risk or complex patients are recommended in the European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines ...
Aug 26, 2022
0
5
Researchers at the National Institutes of Health have found that a novel blood test can be used to easily evaluate disease severity in patients with pulmonary arterial hypertension (PAH) and predict survivability. PAH is ...
Aug 25, 2022
0
36
Clinical researchers at Hannover Medical School (MHH) have succeeded for the first time in stopping the usually fatal course of pulmonary hypertension thanks to a novel therapeutic approach. A three-year-old girl suffering ...
Jun 10, 2022
0
168
Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the lungs, in which blood vessels are narrowed, blocked or destroyed, causing the heart to work harder and, in time, result in cardiac weakness and ...
May 6, 2022
0
106
Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs and heart.
Sep 30, 2021
0
1
Health care experts urge increased awareness of obstructive sleep apnea among people with cardiovascular disease or risk factors such as high blood pressure, according to a new scientific statement from the American Heart ...
Jun 21, 2021
0
4
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon—thanks to a computer algorithm—become even more accurate.
Apr 21, 2021
0
10
For patients receiving background therapy for pulmonary arterial hypertension, treatment with sotatercept results in a reduction in pulmonary vascular resistance, according to a study published in the April 1 issue of the ...
Apr 1, 2021
0
5
Pulmonary arterial hypertension (PAH) is a rare—albeit deadly—disease that affects the arteries of the lung. In PAH, abnormal growth of cells of the vascular media—or the elastic wall—of the pulmonary arteries, called ...
Aug 7, 2020
0
4
A study recently published in the journal Circulation looks at temporal trends in the burden of comorbidities and associated risk of mortality among patients with heart failure (HF) with preserved ejection fraction (HFpEF), ...
Jul 30, 2020
0
4
